Literature DB >> 18181716

Health-benefit claims for probiotic products.

James T Heimbach1.   

Abstract

Manufacturers wish to communicate the benefits of probiotics in advertising and labeling with lawful and adequately substantiated claims. Regulatory and substantiation requirements differ for products intended to cure, treat, prevent, or mitigate a disease; to reduce a healthy individual's risk of developing a disease; or to affect the structure or function of the body. Food labeling is regulated by the US Food and Drug Administration, and advertising is regulated by the Federal Trade Commission; the standards and methods used by these agencies differ. Food manufacturers must design their claims regarding the benefits of probiotics with the regulatory environment in mind and must develop their research plans to provide evidence that satisfies the agencies' substantiation requirements. This article offers an overview of the applicable laws and regulations, what they mandate regarding legitimate claims, and the issues regarding the design of research to substantiate such claims.

Mesh:

Year:  2008        PMID: 18181716     DOI: 10.1086/523327

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  6 in total

Review 1.  Fluorescent reporter systems for tracking probiotic lactic acid bacteria and bifidobacteria.

Authors:  José M Landete; Margarita Medina; Juan L Arqués
Journal:  World J Microbiol Biotechnol       Date:  2016-06-04       Impact factor: 3.312

2.  Probiotics for vaginal health in South Africa: what is on retailers' shelves?

Authors:  Anna-Ursula Happel; Shameem Z Jaumdally; Tanya Pidwell; Tracy Cornelius; Heather B Jaspan; Remy Froissart; Shaun L Barnabas; Jo-Ann S Passmore
Journal:  BMC Womens Health       Date:  2017-01-19       Impact factor: 2.809

3.  Randomised controlled trial of Lactobacillus rhamnosus (LGG) versus placebo in children presenting to the emergency department with acute gastroenteritis: the PECARN probiotic study protocol.

Authors:  David Schnadower; Phillip I Tarr; T Charles Casper; Marc H Gorelick; Michael J Dean; Karen J O'Connell; Prashant Mahajan; Thomas H Chun; Seema R Bhatt; Cindy G Roskind; Elizabeth C Powell; Alexander J Rogers; Cheryl Vance; Robert E Sapien; Feng Gao; Stephen B Freedman
Journal:  BMJ Open       Date:  2017-09-24       Impact factor: 2.692

4.  Regulatory oversight and safety of probiotic use.

Authors:  Veena Venugopalan; Kimberly A Shriner; Annie Wong-Beringer
Journal:  Emerg Infect Dis       Date:  2010-11       Impact factor: 6.883

5.  Probiotics in the arabian gulf region.

Authors:  Abiola C Senok
Journal:  Food Nutr Res       Date:  2009-03-04       Impact factor: 3.894

6.  Impact of emergency department probiotic treatment of pediatric gastroenteritis: study protocol for the PROGUT (Probiotic Regimen for Outpatient Gastroenteritis Utility of Treatment) randomized controlled trial.

Authors:  Stephen B Freedman; Sarah Williamson-Urquhart; Suzanne Schuh; Philip M Sherman; Ken J Farion; Serge Gouin; Andrew R Willan; Ron Goeree; David W Johnson; Karen Black; David Schnadower; Marc H Gorelick
Journal:  Trials       Date:  2014-05-14       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.